Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Stuttgart
18.09.25 | 07:38
2,982 Euro
+2,05 % +0,060
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
3,0103,11810:43
3,0063,11610:44

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
Zeit Aktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:17Citi Raises FOSUN PHARMA's TP to HKD35.3, Re-focuses on R&D Monetization Potential3
MiFOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT2
MiFOSUN PHARMA (02196): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT2
MiFOSUN PHARMA (02196): INTERIM REPORT 20255
MoFOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY6
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
09.09.M Stanley: FOSUN PHARMA to See Turnaround; Rating Upgraded to Overweight19
08.09.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL OF DRUG CLINICAL TRIAL OF A SUBSIDIARY3
08.09.HSI Closes Midday at 25,508, Up 90 pts; HSTI Closes Midday at 5,702, Up 15 pts; BABA Up over 3%; WUXI BIO, CHOW TAI FOOK, FOSUN PHARMA, HORIZONROBOT-W, CHINA LESSO Hit New Highs27
29.08.Accro Bioscience Grants Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor in Greater China20
28.08.CLSA: FOSUN PHARMA ESOP Enhances Growth Visibility; TP Elevated to $29.66
27.08.China's Fosun Pharma Grants UK Peer Sitala Overseas Rights to Its Innovative Drug5
26.08.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION-
26.08.FOSUN PHARMA (02196): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 20253
26.08.Fosun Pharma Announces 2025 Interim Results443Enhancing Innovation Efficiency and Steadily Expanding Globally SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group)...
► Artikel lesen
26.08.FOSUN PHARMA (02196): DISCLOSEABLE AND CONTINUING CONNECTED TRANSACTION RENEWAL OF FINANCIAL SERVICES AGREEMENT3
22.08.FOSUN PHARMA (02196): PROPOSED ADOPTION OF THE 2025 A SHARE OPTION SCHEME5
12.08.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION16
12.08.Fosun Pharma Rises After Unit Sells Rights to Novel Lung Disease Drug Outside China for USD645 Million7
08.08.FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - COMPLETION OF THE ISSUANCE OF THE SECOND TRANCHE SCIENTIFIC AND TECHNOLOGICAL INNOVATION BONDS FOR 20255
08.08.FOSUN PHARMA (02196): DATE OF BOARD MEETING8
Weiter >>
87 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1